CIMT 2022 Poster Award Winners

At the 2022 CIMT Annual Meeting, seven early-career researchers were chosen by an international jury to receive the CIMT Poster Awards for best poster presentations in six categories.

‍

Cellular Therapy

Miranda H. Meeuwsen  
Leiden University Medical Center, Netherlands 

Abstract 119 
“T cell receptor-based targeting of immunoglobulin constant domains for treatment of Multiple Myeloma” 


Therapeutic Vaccination

Ida Olsson
Uppsala University/Strike Pharma, Sweden
and
Aman Mebrahtu
KTH Royal Institute of Technology Stockholm/Strike Pharma, Sweden

Abstract 31
“An agonistic CD40 bispecific antibody designed for flexible synthetic peptide-cargo delivery through an affinity interaction, a way to ensure optimal T cell activation”

 

New Targets and New Leads

Marit van Elsas
Leiden University Medical Center, Netherlands

Abstract 77
“CD163 tissue-resident macrophages drive primary and secondary cancer immunotherapy resistance” 


Immunomonitoring

Simone Blaess
University of Tübingen/Werner Siemens Imaging Center, Germany

Abstract 79 
“In vivo T cell activation kinetics visualized by longitudinal OX40- and CD69-immunoPET during combination cancer immunotherapy” 


Tumor Biology & Interaction with the Immune System

Christian Schmidl  
Leibniz Institute for Immunotherapy, Germany

Abstract #171 
“Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor infiltrating T cells” 

Improving Immunity

Matthieu Besneux 
Prokarium, United Kingdom 

Abstract 182
“ZH9: a live bacterial immunotherapy that reprograms suppressive macrophages and induces trained immunity” 


We would like to thank Immatics for their generous support of the 2022 Poster Awards.

 

Christine Castle